Home » Topics » Disease categories and therapies » Cancer

Cancer
RSS

Mode of action of Oxigene's CA4P supported by preclinical data

July 2, 2001

Matrix commences new phase II IntraDose study for primary liver cancer

July 2, 2001

TLK-286 enters phase II trial for non-small cell lung cancer

July 2, 2001

New data for Gleevec show increase in CML response rates over time

June 29, 2001

Immunomedics and IBC report on bispecific antibody studies

June 29, 2001

Cytokinetics and GlaxoSmithKline establish cancer drug discovery alliance

June 28, 2001

GenVec and Varian Medical extend collaborative agreement for treatment of cancer

June 28, 2001

Licensing opportunity from NIH: methods of treating cancer, diabetes based on adrenomedullin

June 28, 2001

Positive phase I results reported for Active Biotech's TTS

June 27, 2001

Novuspharma's IND for BBR-2778 accepted by FDA

June 27, 2001

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Jan 13, 2025.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for Jan. 13, 2026.
ADCs’ breakout 2025 and their still-unfinished potential
BioWorld
Over the course of the year, and continuing into the latest scientific meetings, an extraordinary breadth of new antibody-drug conjugate (ADC) designs was...
Science in 2025: the best of the rest
BioWorld Science
A review of 2025's noteworthy advances in medical research, including GLP-1 receptor agonists as anti-aging drugs, tumor-agnostic therapies and xenotransplants.
LINC01116 has prognostic value in lung cancer, study shows
BioWorld MedTech
Long noncoding RNAs (lncRNAs) have emerged as potential markers of disease, since they associate with proteins that regulate gene expression, translation or...